(Q40069166)

17 September 2017

title

Cross-trial prediction of treatment outcome in depression: a machine learning approach (English)

1 reference

17 September 2017

0 references

Adam Mourad Chekroud

1

0 references

Ralitza Gueorguieva

object named as

Ralitza Gueorguieva

4

0 references

Tyrone Cannon

7

object named as

Tyrone D Cannon

1 reference

17 September 2017

Ryan Joseph Zotti

2

1 reference

17 September 2017

Zarrar Shehzad

3

1 reference

17 September 2017

Marcia K Johnson

5

1 reference

17 September 2017

Madhukar H Trivedi

6

1 reference

17 September 2017

John Harrison Krystal

8

1 reference

17 September 2017

Philip Robert Corlett

9

1 reference

17 September 2017

publication date

20 January 2016

1 reference

17 September 2017

published in

The Lancet Psychiatry

1 reference

17 September 2017

volume

3

1 reference

17 September 2017

issue

3

1 reference

17 September 2017

page(s)

243-250

1 reference

Selecting among second-step antidepressant medication monotherapies: predictive value of clinical, demographic, or first-step treatment features

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Managing depression as a chronic disease: a randomised trial of ongoing treatment in primary care

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Fluoxetine versus other types of pharmacotherapy for depression

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Medicine. Brain disorders? Precisely

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

APACHE—acute physiology and chronic health evaluation: a physiologically based classification system

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Risk prediction for breast, endometrial, and ovarian cancer in white women aged 50 y or older: derivation and validation from population-based cohort studies

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Predicting Nonsentinel Node Status After Positive Sentinel Lymph Biopsy for Breast Cancer: Clinicians Versus Nomogram

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Clinicians versus nomogram: predicting future technetium-99m bone scan positivity in patients with rising prostate-specific antigen after radical prostatectomy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Identifying predictors, moderators, and mediators of antidepressant response in major depressive disorder: neuroimaging approaches

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Common genetic variation and antidepressant efficacy in major depressive disorder: a meta-analysis of three genome-wide pharmacogenetic studies

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

A clinical risk stratification tool for predicting treatment resistance in major depressive disorder

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Cues they use: clinicians' endorsement of risk cues in predictions of dangerousness

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

The STAR*D Project results: a comprehensive review of findings.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

A self-report scale to help make psychiatric diagnoses: the Psychiatric Diagnostic Screening Questionnaire.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Predicting suicides after psychiatric hospitalization in US Army soldiers: the Army Study To Assess Risk and rEsilience in Servicemembers (Army STARRS).

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Regularization and variable selection via the elastic net

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Regularization Paths for Generalized Linear Models via Coordinate Descent

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Diagnostic exome sequencing in persons with severe intellectual disability

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Exceeding chance level by chance: The caveat of theoretical chance levels in brain signal classification and statistical assessment of decoding accuracy

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Nomograms for predicting graft function and survival in living donor kidney transplantation based on the UNOS Registry.

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Assessing individual risk for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Prognostic nomogram for patients undergoing resection for adenocarcinoma of the pancreas

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Comparative effectiveness of biomarkers and clinical indicators for predicting outcomes of SSRI treatment in Major Depressive Disorder: results of the BRITE-MD study

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Biomarkers to predict antidepressant response

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Depression is not a consistent syndrome: An investigation of unique symptom patterns in the STAR*D study

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Personalised pharmacotherapy: an interim solution for antidepressant treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

Pragmatism Instead of Mechanism: A Call for Impactful Biological Psychiatry

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

What if a placebo effect explained all the activity of depression treatments?

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

The Personalized Advantage Index: translating research on prediction into individualized treatment recommendations. A demonstration

1 reference

https://api.crossref.org/works/10.1016%2FS2215-0366%2815%2900471-X

7 January 2021

10.1016/S2215-0366(15)00471-X

Identifiers

DOI

1 reference

17 September 2017

1 reference